Role of Targeted Therapy in Dilated Cardiomyopathy: The Challenging Road Toward a Personalized Approach

J Am Heart Assoc. 2019 Jun 4;8(11):e012514. doi: 10.1161/JAHA.119.012514. Epub 2019 Jun 1.
No abstract available

Keywords: dilated cardiomyopathy; personalized; phenotyping; therapy.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Cardiomyopathy, Dilated / diagnosis
  • Cardiomyopathy, Dilated / drug therapy*
  • Cardiomyopathy, Dilated / genetics
  • Cardiomyopathy, Dilated / physiopathology
  • Cardiovascular Agents / adverse effects
  • Cardiovascular Agents / therapeutic use*
  • Clinical Decision-Making
  • Genetic Predisposition to Disease
  • Genetic Testing*
  • Humans
  • Patient Selection
  • Phenotype
  • Precision Medicine*
  • Predictive Value of Tests
  • Risk Assessment
  • Risk Factors
  • Treatment Outcome

Substances

  • Cardiovascular Agents